Loading…
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
62pct
4d open
vs 10,564 other HR bills in the 118th — cohort avg 68d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (5)
2024 · fourth_quarter · Health Issues
SUPPORT for Patients and Communities Reauthorization Act (HR 4531 / S 2433, S 3106, S 3393); HEAL Act (HR 4007 / S 2809); PAHPA Act (HR 4421 / S 2333); Reentry Act (HR 2400 / S 1165); Due Process Continuity of Care Act (HR 3074 / S 971); FY25 appropriations for Labor-HHS-Education, Military Construction & Veterans Affairs, and Commerce-Justice-Science; DEA rulemaking on telemedicine prescribing of controlled substances (RIN #1117-AB40); CMS Physician Fee Schedule CY25 Proposed Rule (RIN #0938-AV33);Continuing appropriations for FY25 (HR 9747, HR 10545)
Referred to the Subcommittee on Health.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $230,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
2024 · fourth_quarter · Pharmacy
Issues related to overdose reversal products; H.R.4531/S.3393, SUPPORT for Patients and Communities Reauthorization Act; H.R.4007/S.2809, Halting the Epidemic of Addiction and Loss Act of 2023; H.R.9029/S.4942, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025; H.R.8070/S.4638, National Defense Authorization Act for Fiscal Year 2025, issues related to Naloxone; H.R.10445, Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Health Issues
SUPPORT for Patients and Communities Reauthorization Act (HR 4531 / S 2433, S 3106, S 3393); HEAL Act (HR 4007 / S 2809); PAHPA Act (HR 4421 / S 2333); Reentry Act (HR 2400 / S 1165); Due Process Continuity of Care Act (HR 3074 / S 971); FY25 appropriations for Labor-HHS-Education, Military Construction & Veterans Affairs, and Commerce-Justice-Science; DEA rulemaking on telemedicine prescribing of controlled substances (RIN #1117-AB40); CMS Physician Fee Schedule CY25 Proposed Rule (RIN #0938-AV33)
Client expense: $230,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
2024 · third_quarter · Pharmacy
Issues related to overdose reversal products; H.R.4531/S.3393, SUPPORT for Patients and Communities Reauthorization Act; H.R.4007/S.2809, Halting the Epidemic of Addiction and Loss Act of 2023; H.R.9029/S.4942, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025; H.R.8070/S.4638, National Defense Authorization Act for Fiscal Year 2025, issues related to Naloxone.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Health Issues
SUPPORT for Patients and Communities Reauthorization Act (HR 4531 / S 2433, S 3106, S 3393); HEAL Act (HR 4007 / S 2809); PAHPA Act (HR 4421 / S 2333); Reentry Act (HR 2400 / S 1165); Due Process Continuity of Care Act (HR 3074 / S 971); FY24 Further Consolidated Appropriations Act (HR 2882), FY25 appropriations for Labor-HHS-Education, Military Construction & Veterans Affairs, and Commerce-Justice-Science; DEA rulemaking on telemedicine prescribing of controlled substances (RIN #1117-AB40)
Client expense: $260,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
2024 · second_quarter · Pharmacy
Issues related to overdose reversal products; H.R.4531/S.3393, SUPPORT for Patients and Communities Reauthorization Act; H.R.4007/S.2809, Halting the Epidemic of Addiction and Loss Act of 2023; FY2025 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations process; FY2025 National Defense Authorization Act (H.R.8070), issues related to Naloxone.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Pharmacy
Issues related to overdose reversal products; H.R.2617, Consolidated Appropriations Act, 2023 (P.L.117-328) implementation; FY2024 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, S.2624/H.R.5894; H.R.4531/S.3393, SUPPORT for Patients and Communities Reauthorization Act; H.R.4007/S.2809, Halting the Epidemic of Addiction and Loss Act of 2023; FY2025 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations process.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Health Issues
FY24 Labor-HHS-Education (HR 5894 / S 2624), Military Construction & Veterans Affairs (HR 4366 / S 2127) and Commerce-Justice-Science (HR 5893 / S 2321) Appropriations; SUPPORT for Patients and Communities Reauthorization Act (HR 4531 / S 2433, S 3106, S 3393); HEAL Act (HR 4007 / S 2809); PAHPA Act (HR 4421 / S 2333); Reentry Act (HR 2400 / S 1165); Due Process Continuity of Care Act (HR 3074 / S 971); FY24 Further Consolidated Appropriations Act (HR 2882), FY25 appropriations for Labor-HHS-Education, Military Construction & Veterans Affairs, and Commerce-Justice-Science
Client expense: $270,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
2023 · fourth_quarter · Health Issues
FY24 Labor-HHS-Education (HR 5894 / S 2624), Military Construction & Veterans Affairs (HR 4366 / S 2127) and Commerce-Justice-Science (HR 5893 / S 2321) Appropriations; SUPPORT for Patients and Communities Reauthorization Act (HR 4531 / S 2433, S 3106, S 3393); HEAL Act (HR 4007 / S 2809); PAHPA Act (HR 4421 / S 2333); Reentry Act (HR 2400 / S 1165); Due Process Continuity of Care Act (HR 3074 / S 971)
Client expense: $270,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
2023 · fourth_quarter · Pharmacy
Issues related to overdose reversal products; H.R.2617, Consolidated Appropriations Act, 2023 (P.L.117-328) implementation; FY2024 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, S.2624/H.R.5894; H.R.4531/S.3393, SUPPORT for Patients and Communities Reauthorization Act; H.R.4007/S.2809, Halting the Epidemic of Addiction and Loss Act of 2023.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
2023 · third_quarter · Health Issues
FY24 Labor-HHS-Education (HR 5894 / S 2624), Military Construction & Veterans Affairs (HR 4366 / S 2127) and Commerce-Justice-Science (HR 5893 / S 2321) Appropriations; SUPPORT Act of 2023 (HR 4531 / S 2433); HEAL Act (HR 4007 / S 2809); PAHPA Act (HR 4421 / S 2333); Reentry Act (HR 2400 / S 1165); Due Process Continuity of Care Act (HR 3074 / S 971)
Client expense: $280,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
2023 · third_quarter · Health Issues
Affordability is Access Act HR 3589/S 1698 Right to Contraception Act HR 4121/S 1999 Black Maternal Health Momnibus HR 3305/S 1606 Enhancing Questions to Understand Intentions for Pregnancy (EQUIP) Act HR 3659 Anti-Racism in Public Health Act HR 2904/S 1317 Establishing Office of Sexual and Reproductive Health HR 4281 Resolution Opposing Criminalization of People Seeking Essential Health Care H Res 561 Convenient Contraception Act HR 4816 / S 2427 Reproductive Health Care Accessibility Act HR 4901 / S 2544 HEAL Act HR 4007 / S 2809 World Contraception Day Resolution H Res 68
Client expense: $22,842 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · second_quarter · Health Issues
Legislation and rulemakings relating to opioid abuse and Naloxone access; H.R. 4007, the HEAL Act; H.R. 4531, the Support for Patients and Communities Reauthorization Act.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · second_quarter · Health Issues
H.Res. 436 - Expressing Support for the Designation of the Week of May 22 through26, 2023, as Educator Mental Health Awareness Week" H.R. 498 - 988 Lifeline Cybersecurity Responsibility Act H.R. 734 - Protection of Women and Girls in Sports Act of 2023 H.R. 824 - Telehealth Benefit Expansion for Workers Act of 2023 H.R. 1114 - Long COVID Recovery Now Act H.R. 1201 - Increasing Behavioral Health Treatment Act H.R. 1202 - REDI Act H.R. 1359 / S. 644 - Modernization of Opioid Treatment Act H.R. 1502 - Comprehensive Opioid Recovery Centers (CORC) Reauthorization Act H.R. 1711 / S. 940 - Rural America Health Corps Act H.R. 1839 - Combating Illicit Xylazine Act H.R. 2389 - Resident Physician Shortage Reduction Act of 2023 H.R. 2400 / S. 1165 - Reentry Act of 2023 H.R. 2412 - Helping Kids Cope Act H.R. 2474 - Strengthening Medicare for Patients and Providers Act H.R. 2713 - I CAN Act H.R. 3073 / S. 1452 - Community Mental Wellness and Resilience Act of 2023 H.R. 3074 / S. 971 - Due Process Continuity of Care Act H.R. 3150 / S. 983 - OPIOIDS Act H.R. 3305 / S. 1606 - Black Maternal Health Momnibus Act H.R. 3548 / S. 1700 Pursuing Equity in Mental Health Act H.R. 3713 / S. 1884 Mental Health Services for Students Act H.R.3570 - Comprehensive Response to Fentanyl-Related Substances and Fentanyl-laced Substances Act H.R.3680 - Stop Mental Health Stigma in Our Communities Act H.R. 3736 - Extending Access to Addiction Treatment Act H.R. 3752 - Parity Enforcement Act of 2023 H.R. 3836 - Medicaid Primary Care Improvement Act H.R. 3838 - Preventing Maternal Deaths Reauthorization Act H.R. 3841 - To amend title III of the Public Health Service Act to reauthorize the program of payments to children's hospitals that operate graduate medical education programs. H.R. 3887 - Childrens Hospital GME Support Reauthorization Act of 2023 H.R. 3892 - Improving Mental Health and Drug Treatment Act H.R. 4007 - HEAL Act H.R. 4053 - Studying Suboxone Act H.R. 4054 - Trauma Support and Mental Health in Schools Reauthorization Act H.R. 4056 - Ensuring Medicaid Continuity for Children in Foster Care Act of 2023 H.R. 4057 - Keeping Kids Safe Act H.R. 4063 - FIND Fentanyl Act of 2023 H.R. 4079 - Substance Use Disorder Treatment and Recovery Loan Repayment Program Reauthorization Act of 2023 H.R. 4080 - Trauma-Informed Care Task Force Reauthorization Act of 2023 H.R. 4088 - CAREER Act H.R. 4089 - Safer Response Act H.R. 4091 - Combatting Substance Use Disorder Act H.R. 4092 - Protecting Moms and Infants Reauthorization Act H.R. 4093 - Remote Opioid Monitoring Act of 2023 H.R. 4095 - Save Children from Trauma Act H.R. 4096 - A bill to amend title XIX of the Social Security Act to expand the application of Medicaid State programs to monitor antipsychotic medications to all Medicaid beneficiaries H.R. 4097 - Mental Health Improvement Act H.R. 4098 - Communities of Recovery Reauthorization Act H.R. 4099 - RECONNECTS Act of 2023 H.R. 4100 - To amend the Public Health Service Act to reauthorize a monitoring and education program regarding infections associated with illicit drug use and other risk factors H.R. 4101 - Road to Recovery Act H.R. 4106 - To amend the 21st Century Cures Act to expressly authorize the use of certain grants to implement substance use disorder and overdose prevention activities with respect to fentanyl and xylazine test strips H.R. 4189 / S. 2016 - CONNECT for Health Act S. 462 - Mental Health Professionals Workforce Shortage Loan Repayment Act S. 665 - Conrad State 30 and Physician Access Reauthorization Act S. 669 - Increasing Mental Health Options Act of 2023 S. 923 - Better Mental Health Care for Americans Act S.1378 - Connecting Our Medical Providers with Links to Expand Tailored and Effective (COMPLETE) Care Act S. 1426 - RISE from Trauma Act
| Democratic |
| MD |
| David P. Joyce | Republican | OH |
| Derek Kilmer | Democratic | WA |
| Don Bacon | Republican | NE |
| Michael Lawler | Republican | NY |
| Paul Tonko | Democratic | NY |
Client expense: $193,806 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE